The current earnings forecast score of Resmed Inc is 6.76, ranking 157 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 300.00, with a high of 335.00 and a low of 225.00.

Analyst Rating

Based on 21 analysts

Hold

Current Rating

248.567

Target Price

+11.40%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Resmed Inc

RMD

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Thermo Fisher Scientific Inc

TMO

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

...

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Forecast

Actual

FAQs

What is Resmed Inc's expected revenue for the next quarter?



Resmed Inc's expected revenue is 1.42B.

What is Resmed Inc's price target?



Analysts forecast that Resmed Inc's price target is USD 300.00, with the highest forecast at USD 335.00 and the lowest forecast at USD 225.00.

How have Resmed IncRMD's recent earnings per share performed?



The market expectation was USD 2.65, while Resmed IncRMD's earnings per share (EPS) for the previous quarter was USD 2.74. EPS for the next quarter is expected at USD 2.82.

What is the analyst rating for Resmed Inc?



Based on the ratings of Resmed Inc's stock from 21 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.